Prognostic Significance of RB1 Alterations on Outcomes in Metastatic Prostate Cancer

By afschroeder • September 20, 2025

Raychaudhuri R, Garraway IP, Maxwell KN, Rettig M, Desai H, Schoen MW, Schweizer MT, Beltran H, Nelson PS, Montgomery B. Prognostic Significance of RB1 Alterations on Outcomes in Metastatic Prostate Cancer. JCO Precis Oncol. 2025 Sep;9:e2500341. doi: 10.1200/PO-25-00341. Epub 2025 Sep 19. PMID: 40971752; PMCID: PMC12453595.

Tags: Hematology/Oncology, Publications, Veterans Administration

Related Posts

The Randomized Phase 2 ARC-9 Study of Etrumadenant-Based Therapy vs Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer

Cecchini M, Han SW, Lee S, Lee KW, Kopetz S, Mizrahi J, Hong YS, Ghiringhelli F, Italiano A, Tougeron D, Beagle B, Boakye M, Zhao[...]

Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia

Rugo HS, Tolaney SM, Cortés J, Marmé F, de Azambuja E, Xu B, Sohn J, Naito Y, Valdez T, Gary D, Zhu J, Lai C,[...]

Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering

Chen X, Mao Z, Kolawole EM, Persechino M, Jude KM, Ogishi M, Mo KC, McLaughlin J, Cheng D, Xiang X, Yang X, Gee C, Liu[...]